Original paper
Ivermectin and COVID-19: Keeping Rigor in Times of Urgency
Volume: 102, Issue: 6, Pages: 1156 - 1157
Published: Apr 17, 2020
Abstract
critically ill patients.A path to consider is evaluation first of impacts on virologic outcomes in uncomplicated, low-risk patients early in the course of the disease.Well-conducted clinical trials informed by robust pharmacokinetic models should be considered to validate the impact before the use of ivermectin to treat SARS-CoV-2 is...
Paper Details
Title
Ivermectin and COVID-19: Keeping Rigor in Times of Urgency
Published Date
Apr 17, 2020
Volume
102
Issue
6
Pages
1156 - 1157